Gabapentin Capsule
Product Images NDC 76282-627

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 76282-627). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-capsules-formula.jpg (Gabapentin Capsules Formula)

This image displays a formula for calculating creatinine clearance (CLCr). The formula uses patient age in years, weight in kilograms, serum creatinine level in mg/dL, and applies a multiplication factor of 0.85 for female patients, reflecting renal function assessment metrics.*

FDA Label Image

Gabapentin-capsules-str.jpg (Gabapentin Capsules Str)

Chemical structure of gabapentin showing a cyclohexane ring attached to a carbon with amino and carboxylic acid functional groups.*

FDA Label Image

Gabapentin-capsules-fig01.jpg (Gabapentin Capsules Fig01)

A line graph showing mean pain scores over 8 weeks comparing placebo to Gabapentin 3600 mg/day. The x-axis represents weeks, including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin scores decrease over time, while placebo scores remain relatively stable.*

FDA Label Image

Gabapentin-capsules-fig02.jpg (Gabapentin Capsules Fig02)

A line graph showing mean pain scores over a 7-week period, comparing placebo with gabapentin at 1800 mg/day and 2400 mg/day. The x-axis represents weeks divided into a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain score values from 0 to 10. Both gabapentin doses show decreasing pain scores over time compared to placebo.*

FDA Label Image

Gabapentin-capsules-fig03.jpg (Gabapentin Capsules Fig03)

A bar graph titled 'Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing response rates in two studies. Study 1 compares placebo (12%) and GBP 3600 (29%). Study 2 compares placebo (14%) with GBP 1800 (32%) and GBP 2400 (34%). Statistical significance markers indicate p-values less than 0.01 and 0.001 respectively.*

FDA Label Image

Gabapentin-capsules-fig04.jpg (Gabapentin Capsules Fig04)

A scatter plot graph showing the percentage difference on the y-axis versus daily dose in mg on the x-axis for gabapentin. The graph compares three studies labeled 'a', 'b', and 'c' with markers in black, gray, and white respectively, illustrating the difference percentages at various daily doses ranging from around 600 to 1800 mg.*

FDA Label Image

Gabapentin 100mg (90 Capsules).jpg (Gabapentin 100mg (90 Capsules))

Label for Gabapentin Capsules USP 100 mg by Exelan Pharmaceuticals, Inc. The label states the dosage strength as 100 mg per capsule and indicates a package size of 90 capsules. It includes instructions for pharmacists to dispense with an attached medication guide. The label also notes storage conditions and lists the manufacturers: InvaGen Pharmaceuticals, Inc., and Exelan Pharmaceuticals, Inc.*

FDA Label Image

Gabapentin 100mg (100 Capsules).jpg (Gabapentin 100mg (100 Capsules))

Label for Gabapentin capsules, USP 100 mg, by Exelan Pharmaceuticals, Inc. The label states "PHARMACIST: PLEASE DISPENSE WITH ATTACHED MEDICATION GUIDE." It indicates 100 capsules per container, includes storage instructions at 20° to 25°C, and provides manufacturer details for InvaGen Pharmaceuticals and Exelan Pharmaceuticals.*

FDA Label Image

Gabapentin 100mg (180 Capsules).jpg (Gabapentin 100mg (180 Capsules))

Gabapentin Capsules, USP 100 mg oral capsules package label from Exelan Pharmaceuticals, Inc. The label includes the NDC 76282-321-18, barcode, quantity of 180 capsules, and prescription use notice. It states each capsule contains 100 mg gabapentin, storage instructions at 20° to 25°C, and manufacturer information including InvaGen Pharmaceuticals, Inc., a Cipla subsidiary, and Exelan Pharmaceuticals, Inc.*

FDA Label Image

Gabapentin 100mg (270 Capsules).jpg (Gabapentin 100mg (270 Capsules))

Label for Gabapentin Capsules, USP 100 mg from Exelan Pharmaceuticals, Inc. The label includes the NDC 76282-321-27 and states the package contains 270 capsules. It provides storage instructions and manufacturer details, including InvaGen Pharmaceuticals, Inc. as the manufacturer and Exelan Pharmaceuticals, Inc. as the labeler.*

FDA Label Image

Gabapentin 100mg (500 Capsules).jpg (Gabapentin 100mg (500 Capsules))

Label for Gabapentin Capsules, USP 100 mg by Exelan Pharmaceuticals, Inc. The label shows the product name, strength (100 mg), dosage form (capsules), quantity (500 capsules), and Rx only indication. It includes storage instructions and manufacturer information for InvaGen Pharmaceuticals, Inc. and Exelan Pharmaceuticals, Inc.*

FDA Label Image

Gabapentin 300mg (30 Capsules).jpg (Gabapentin 300mg (30 Capsules))

Label of Gabapentin Capsules, USP 300 mg oral capsules. Contains 30 capsules per bottle, labeled for prescription use only. Manufactured by InvaGen Pharmaceuticals, a subsidiary of Cipla Ltd., and manufactured for Exelan Pharmaceuticals, Inc. The label includes storage instructions and dispensing guidance with an attached medication guide.*

FDA Label Image

Gabapentin 300mg (60 Capsules).jpg (Gabapentin 300mg (60 Capsules))

Label for Gabapentin Capsules, USP 300 mg by Exelan Pharmaceuticals, Inc. The label states the dosage strength as 300 mg per capsule, with 60 capsules per package. It includes storage instructions at 20° to 25°C and notes the manufacturer InvaGen Pharmaceuticals, Inc. and Exelan Pharmaceuticals, Inc. It directs pharmacists to dispense with an attached medication guide and provides the Rx Only designation.*

FDA Label Image

Gabapentin 300mg (90 Capsules).jpg (Gabapentin 300mg (90 Capsules))

Label for Gabapentin Capsules, USP 300 mg oral capsules, containing 90 capsules per bottle. The label states pharmacist dispensing instructions and storage temperature of 20° to 25°C. Manufactured by InvaGen Pharmaceuticals, Inc. and labeled for Exelan Pharmaceuticals, Inc.*

FDA Label Image

Gabapentin 300mg (100 Capsules).jpg (Gabapentin 300mg (100 Capsules))

Label for Gabapentin Capsules, USP 300 mg by Exelan Pharmaceuticals, Inc. The label includes the NDC 76282-627-01 and states each capsule contains 300 mg of gabapentin. It instructs pharmacists to dispense with the attached medication guide and notes storage between 20° to 25°C (68° to 77°F). The label indicates it is Rx only and contains 100 capsules, manufactured by InvaGen Pharmaceuticals, Inc. for Exelan Pharmaceuticals.*

FDA Label Image

Gabapentin 300mg (180 Capsules).jpg (Gabapentin 300mg (180 Capsules))

Label for Gabapentin Capsules, USP 300 mg, an oral prescription medication by Exelan Pharmaceuticals, Inc. The label indicates a package of 180 capsules, includes storage temperature guidance, and notes that the capsules contain 300 mg of gabapentin. Manufactured by InvaGen Pharmaceuticals, Inc., a subsidiary of Cipla Ltd., and labeled for pharmacist dispensing with an attached medication guide.*

FDA Label Image

Gabapentin 300mg (270 Capsules).jpg (Gabapentin 300mg (270 Capsules))

Label for Gabapentin Capsules, USP 300 mg, an oral prescription drug by Exelan Pharmaceuticals, Inc. The label states each capsule contains 300 mg of gabapentin, and the package contains 270 capsules. It includes storage instructions (20° to 25°C) and manufacturer details: InvaGen Pharmaceuticals, a Cipla subsidiary, Hauppauge, NY, and Exelan Pharmaceuticals, Boca Raton, FL.*

FDA Label Image

Gabapentin 300mg (500 Capsules).jpg (Gabapentin 300mg (500 Capsules))

Label for Gabapentin Capsules USP 300 mg by Exelan Pharmaceuticals, Inc. The label indicates oral capsules in a package of 500. It includes storage instructions at controlled room temperature and manufacturing details for InvaGen Pharmaceuticals, Inc., a Cipla subsidiary, and Exelan Pharmaceuticals, Inc. The label also features a barcode and a note to dispense with an attached medication guide.*

FDA Label Image

Gabapentin 400mg (90 Capsules).jpg (Gabapentin 400mg (90 Capsules))

Label for Gabapentin Capsules, USP 400 mg oral capsules by Exelan Pharmaceuticals, Inc. The label includes storage instructions, prescribing information notice, and states the package contains 90 capsules. Manufactured by InvaGen Pharmaceuticals, Inc. with detailed labeling including NDC 76282-323-90 and barcode.*

FDA Label Image

Gabapentin 400mg (100 Capsules).jpg (Gabapentin 400mg (100 Capsules))

Label for Gabapentin Capsules, USP 400 mg by Exelan Pharmaceuticals, Inc. The label indicates 100 capsules per container. It includes storage instructions, manufacturer information for InvaGen Pharmaceuticals, and dispensing instructions with a medication guide.*

FDA Label Image

Gabapentin 400mg (270 Capsules).jpg (Gabapentin 400mg (270 Capsules))

Gabapentin Capsules, USP 400 mg oral capsules label from Exelan Pharmaceuticals, Inc. The label states each capsule contains 400 mg of gabapentin. It includes dispensing instructions, storage conditions at 20° to 25°C, and manufacturer information showing InvaGen Pharmaceuticals, Inc. as the manufacturer and Exelan Pharmaceuticals, Inc. as the manufacturer for. The package contains 270 capsules and is labeled Rx only.*

FDA Label Image

Gabapentin 400mg (500 Capsules).jpg (Gabapentin 400mg (500 Capsules))

Label for Gabapentin Capsules USP 400 mg oral capsules by Exelan Pharmaceuticals, Inc. The label indicates a package size of 500 capsules. It includes storage instructions, manufacturer details (InvaGen Pharmaceuticals, Inc.), and notes that each capsule contains 400 mg of gabapentin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.